Literature DB >> 12456926

Reduction of the influenza burden in children.

.   

Abstract

Epidemiologic studies indicate that children with certain chronic conditions, such as asthma, and otherwise healthy children younger than 24 months are hospitalized for influenza and its complications at high rates similar to those experienced by the elderly. Currently, annual influenza immunization is recommended for all children 6 months and older with high-risk conditions. To protect these children more fully against the complications of influenza, increased efforts are needed to identify and recall high-risk children for annual influenza immunization. In addition, immunization of children 6 through 23 months of age and their household contacts and out-of-home caregivers is now encouraged to the extent feasible. The ultimate goal is a universal recommendation for influenza immunization. Issues that need to be addressed before institution of routine immunization of healthy young children include education of physicians and parents about the morbidity caused by influenza, adequate vaccine supply, and appropriate reimbursement of practitioners for influenza immunization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456926     DOI: 10.1542/peds.110.6.1246

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Management of acute otitis media.

Authors:  S Forgie; G Zhanel; J Robinson
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

2.  Influenza related hospitalisations in Sydney, New South Wales, Australia.

Authors:  F Beard; P McIntyre; H Gidding; M Watson
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

3.  Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years.

Authors:  Richard K Zimmerman; Alejandro Hoberman; Mary Patricia Nowalk; Chyongchiou J Lin; David P Greenberg; Stuart T Weinberg; Feng Shou Ko; Dwight E Fox
Journal:  Ann Fam Med       Date:  2006 Nov-Dec       Impact factor: 5.166

4.  Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic.

Authors:  Amy E Sobota; Patricia L Kavanagh; William G Adams; Elizabeth McClure; Delmaude Farrell; Philippa G Sprinz
Journal:  Pediatr Blood Cancer       Date:  2014-12-24       Impact factor: 3.167

5.  Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.

Authors:  Daisuke Tamura; Norio Sugaya; Makoto Ozawa; Ryo Takano; Masataka Ichikawa; Masahiko Yamazaki; Chiharu Kawakami; Hideaki Shimizu; Ritei Uehara; Maki Kiso; Eiryo Kawakami; Keiko Mitamura; Yoshihiro Kawaoka
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

6.  Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system.

Authors:  John S Brownstein; Ken P Kleinman; Kenneth D Mandl
Journal:  Am J Epidemiol       Date:  2005-08-17       Impact factor: 4.897

Review 7.  The impact of influenza on working days lost: a review of the literature.

Authors:  Martin Keech; Paul Beardsworth
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Changes in parents' perceptions of infant influenza vaccination over two years.

Authors:  Mary Patricia Nowalk; Chyongchiou J Lin; Richard K Zimmerman; Feng-Shou Ko; Alejandro Hoberman; Lisa Zoffel; Diana H Kearney
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

9.  Parental perspectives on influenza vaccination among children with asthma.

Authors:  Sangeeth K Gnanasekaran; Jonathan A Finkelstein; Katherine Hohman; Megan O'Brien; Benjamin Kruskal; Tracy Lieu
Journal:  Public Health Rep       Date:  2006 Mar-Apr       Impact factor: 2.792

10.  Comparison of airway measurements during influenza-induced tachypnea in infant and adult cotton rats.

Authors:  Elman L Trias; Arash Hassantoufighi; Gregory A Prince; Maryna C Eichelberger
Journal:  BMC Pulm Med       Date:  2009-06-10       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.